Welcome to chemicalbook!
WhatsApp
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Position:Product Catalog >CF53
CF53
  • CF53

CF53 NEW

Price $75 $182 $272
Package 1mg 5mg 10mg
Supply Ability: 10g
Update Time: 2026-07-27

Product Details

Product Name: CF53 CAS No.: 1808160-52-2
Purity: 99.72% Supply Ability: 10g
Release date: 2026/07/27

Product Introduction

Bioactivity

NameCF53
DescriptionCF53 is a highly potent, selective, and orally active inhibitor of BET protein, with a Ki of <1 nM, Kd of 2.2 nM, and an IC50 of 2 nM for BRD4 BD1. CF53 binds to both the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT BET proteins with high affinities, being very selective over non-BET bromodomain-containing proteins. CF53 exhibits potent anti-tumor activity both in vitro and in vivo.
In vitroCF53 exhibits high binding affinities to the BD1 and BD2 domains of BRD2, BRD3, BRD4, and BRDT within the BET protein family, with dissociation constants (Kds) as follows: 1.1 nM for BRD2 BD1, 0.6 nM for BRD2 BD2, 0.52 nM for BRD3 BD1, 0.49 nM for BRD3 BD2, 0.8 nM for BRD4 BD2, 2 nM for BRDT BD1, and 2.1 nM for BRDT BD2. Additionally, it displays Kds of 47 nM, 570 nM, and 110 nM for CREBBP, CECR2, and EP300, respectively. In terms of biological activity, CF53 shows IC50 values of 7 nM and 85 nM against MOLM-13 acute leukemia and MDA-MB-231 breast cancer cell lines, respectively[1].
In vivoCF53, administered orally at doses of 25 and 50 mg/kg, demonstrates strong anti-tumor efficacy in both the MDA-MB-231 xenograft tumor model and the RS4;11 model in mice[1].
StorageStore under nitrogen, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 72.5 mg/mL (163.47 mM), Sonication is recommended.
10% DMSO+90% Saline : < 7.25 mg/mL (16.35 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 7.25 mg/mL (16.35 mM), Solution.
KeywordsEpigeneticReaderDomain | Epigenetic Reader Domain | EP300 | CREBBP | CF-53 | CF53 | CF 53 | CECR2 | BRDT-BD2 | BRDT-BD1 | BRDT BD2 | BRDT BD1 | BRD4-BD2 | BRD4-BD1 | BRD4(BD1) | BRD4 BD1 | BRD4 (BD2) | BRD3-BD2 | BRD3-BD1 | BRD3 BD2 | BRD3 BD1 | BRD2-BD2 | BRD2-BD1 | BRD2 BD2 | BRD2 BD1
Inhibitors RelatedRibociclib | 3-methyl-1,2,3,4-tetrahydroquinazolin-2-one | 2-Chloropyrazine | Kojic acid | ZEN-3694 | Acetaminophen | Abemaciclib | Manganese chloride (tetrahydrate) | Curcumin | N4-Acetylcytidine | Naphthol AS-E | Sodium Oxamate
Related Compound LibrariesAnti-Pancreatic Cancer Compound Library | Bioactive Compound Library | Kinase Inhibitor Library | Anti-Breast Cancer Compound Library | Inhibitor Library | PPI Inhibitor Library | Orally Active Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Cell Cycle Compound Library | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$75.00
VIP5Y
TargetMol Chemicals Inc.
2026-07-27

TargetMol Chemicals Inc.

7YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY